CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates the role of modified amyloid-beta proteins in Alzheimer's disease pathology. By studying their interactions with tau proteins and how they change with age, the research aims to identify potential therapeutic targets for improving treatments for dementia.
Alzheimer Disease (AD) is the commonest form of dementia, with ageing as the main risk factor.
There are currently over 6 million people with dementia in the European Union (EU).
The increasingly ageing population makes AD an economic and social burden for our society, thus investigating the pathological mechanisms of AD and the characterization of the pharmacological targets are research priorities.
Aggregation of amyloid-Beta (Aβ), upstream of tau phosphorylation, is considered a driving force…
UNIVERSITY OF SOUTHAMPTON
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
